InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (24 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
24
T+90 hit rate
50%
T+90 mean return
+23.6%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Barnett Eva Renee, Chief Financial Officer. Insider active across 1 company, notably Immunovant, Inc.. Aggregated, 30 filings have been published. Split: 0 buy · 24 sells. Total volume traded: €2.6m. Activity tracked since 4 October 2021. The latest transaction was disclosed on 16 April 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations30 total
2,993 shares@ US$14.891.4% of flowCommon StockSEC:0001764013-25-000076:0
7,013 shares@ US$12.993.0% of flowCommon StockSEC:0001764013-25-000067:0
88,878 shares0Common StockSEC:0001764013-25-000051:0
2,814 shares@ US$20.862.0% of flowCommon StockSEC:0001764013-25-000031:0
2,189 shares@ US$23.811.8% of flowCommon StockSEC:0001764013-25-000014:0
4,105 shares@ US$24.103.4% of flowCommon StockSEC:0001764013-25-000004:0
4,174 shares@ US$25.453.6% of flowCommon StockSEC:0001764013-24-000194:0
3,271 shares@ US$28.793.1% of flowCommon StockSEC:0001764013-24-000171:0
5,162 shares@ US$29.565.0% of flowCommon StockSEC:0001764013-24-000166:0
3,619 shares@ US$31.843.7% of flowCommon StockSEC:0001764013-24-000158:0
2,939 shares@ US$29.642.9% of flowCommon StockSEC:0001764013-24-000135:0
4,747 shares@ US$28.064.4% of flowCommon StockSEC:0001764013-24-000127:0
4,042 shares@ US$29.654.0% of flowCommon StockSEC:0001764013-24-000099:0
9,479 shares@ US$28.809.2% of flowCommon StockSEC:0001764013-24-000079:0
3,689 shares@ US$31.183.8% of flowCommon StockSEC:0001764013-24-000073:0
54,978 shares0Common StockSEC:0001764013-24-000046:0
2,930 shares@ US$36.153.5% of flowCommon StockSEC:0001764013-24-000041:0
2,681 shares@ US$41.643.6% of flowCommon StockSEC:0001764013-24-000010:0
3,901 shares@ US$32.754.2% of flowCommon StockSEC:0001764013-23-000144:0
4,557 shares@ US$36.925.7% of flowCommon StockSEC:0001764013-23-000120:0
14,385 shares@ US$20.309.7% of flowCommon StockSEC:0001764013-23-000103:0
2,725 shares@ US$24.942.2% of flowCommon StockSEC:0001764013-23-000080:0
3,423 shares@ US$15.271.7% of flowCommon StockSEC:0001764013-23-000053:0
87,664 shares0Common StockSEC:0001764013-23-000040:0
11 shares@ US$15.150.0% of flowCommon StockSEC:0001764013-23-000008:0
25 of 30 declarations
About Barnett Eva Renee
Eva Renee Barnett is the Chief Financial Officer of Immunovant, Inc. She is responsible for the financial management of the company, including budgeting and financial performance analysis.
